Keep up the assault, pull back when it burrows under to dodge lightning blast, then refocus your attack when it tries to take ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Recent insider activity at Recursion Pharmaceuticals consisted of 1 transaction: a Tax Payment by Ben R Taylor totaling $18,400.36 on September 15, 2026. All reported activity was non-anomalous, with ...